Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Assessment of Marketed AEDs in Photosensitivity Model
NCT00894010Phase 2Completed
- Sponsor
- The Epilepsy Study Consortium
- Start
- May 2009
- Primary completion
- Jun 2011
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of carbamazepine in photosensitive epilepsy (PSE), sponsored by The Epilepsy Study Consortium. Started May 2009; status: completed.
02
Drugs
carbamazepine
03
Conditions
photosensitive epilepsy (PSE)
Beyond the preview
Go deeper on NCT00894010.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00894010.